RT Journal Article
SR Electronic
T1 Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIM<sup>SM</sup> registry
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 102
DO 10.1186/s40425-017-0307-5
VO 5
IS 1
A1 Curti, Brendan
A1 Daniels, Gregory A.
A1 McDermott, David F.
A1 Clark, Joseph I.
A1 Kaufman, Howard L.
A1 Logan, Theodore F.
A1 Singh, Jatinder
A1 Kaur, Meenu
A1 Luna, Theresa L.
A1 Gregory, Nancy
A1 Morse, Michael A.
A1 Wong, Michael K. K.
A1 Dutcher, Janice P.
YR 2017
UL http://jitc.bmj.com/content/5/1/102.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.